A landmark study by Feingold et al. (Gariani et al. 2013) demonstrated that the levels of FGF21 doubled in rodents with sepsis induced by lipopolysaccharide, turpentine and zymosan, paving the way for a new treatment for sepsis and further research. The gene discussed is FGF21; the disease is Sepsis.